Showing results (71-80 of 115) with videos related to
Sort By:
Pageof 12
The Oncologist|August 14, 2021
Framework for Implementing and Tracking a Molecular Tumor Board at a National Cancer Institute-Designated Comprehensive Cancer CenterNeha M Jain, Lauren Schmalz, Christopher Cann, et al.Breast Cancer Research : BCR|May 25, 2017
Mutation site and context dependent effects of ESR1 mutation in genome-edited breast cancer cell modelsAmir Bahreini, Zheqi Li, Peilu Wang, et al.JCO Clinical Cancer Informatics|July 10, 2020
Collaborative, Multidisciplinary Evaluation of Cancer Variants Through Virtual Molecular Tumor Boards Informs Local Clinical PracticesShruti Rao, Beth Pitel, Alex H Wagner, et al.Communications Biology|April 10, 2024
An in vitro CRISPR screen of cell-free DNA identifies apoptosis as the primary mediator of cell-free DNA releaseBrad A Davidson, Adam X Miranda, Sarah C Reed, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 27, 2022
Biomarkers for Systemic Therapy in Metastatic Breast Cancer: ASCO Guideline UpdateN Lynn Henry, Mark R Somerfield, Zoneddy Dayao, et al.Human Pathology|May 15, 2014
Analysis of BRCA2 loss of heterozygosity in tumor tissue using droplet digital polymerase chain reactionRory L Cochran, Karen Cravero, David Chu, et al.Oncotarget|August 7, 2015
Functional isogenic modeling of BRCA1 alleles reveals distinct carrier phenotypesRory L Cochran, Justin Cidado, Minsoo Kim, et al.Clinical Biochemistry|August 4, 2015
Comparison of cell stabilizing blood collection tubes for circulating plasma tumor DNAPatricia Valda Toro, Bracha Erlanger, Julia A Beaver, et al.Cancer Research|September 15, 2017
Structurally Novel Antiestrogens Elicit Differential Responses from Constitutively Active Mutant Estrogen Receptors in Breast Cancer Cells and TumorsYuechao Zhao, Mary J Laws, Valeria Sanabria Guillen, et al.Proteomics|November 5, 2014
A phosphoproteomic screen demonstrates differential dependence on HER3 for MAP kinase pathway activation by distinct PIK3CA mutationsBrian G Blair, Xinyan Wu, Muhammad Saddiq Zahari, et al.Pageof 12